Latest News｜Institute for Biotechnology and Medicine Industry│IBMI

Latest News

Date	Subject	Media
2025-12-13	AnHorn Medicines’ AI-Designed Drug AH-001 Completes U.S. Phase I Trial, Demonstrates Excellent Safety and Tolerability	Research Center for Biotechnology and Medicine Policy, RBMP
2025-12-13	Tanvex BioPharma Targets Year-End Revenue as Cipla Expands Market Share	MoneyDJ
2025-12-13	Chang Gung Memorial Hospital Completes 339 Fecal Microbiota Transplant Treatments, Launches “Gut Microbiome Whole-Genome Analysis” Technology	TechNews
2025-12-13	PEGAVISION Reports Q3 EPS of NT$15.38, Order Visibility Extends to Q1 2026 with Positive Outlook	Economic Daily News
2025-12-13	Pharmosa Biopharm’s L606 Achieves Positive Long-Term Phase III Data in the U.S.; Global PH-ILD Phase III Trial to Commence	Investor
2025-12-13	Hospital Builds Its Own Nursing Robot! China Medical University Leads × EverBot Technology Develops “Healthcare Sovereignty AI”	IBMI
2025-12-13	PuriBlood Medical Partners with Utah Medical to Upgrade Pet Healthcare and Expand Global Reach	Commercial Times
2025-12-13	Acer Medical × FIG × Fujitsu Launch AI Exercise Assessment App to Promote Health-Oriented Insurance	Commercial Times
2025-12-13	Primo Biotechnology Partners with GE Healthcare to Develop Radiopharmaceuticals	Commercial Times
2025-12-13	Bora Pharmaceuticals Achieves Milestone as U.S. Injectable Facility Enters Commercial Production	Economic Daily News

■ Most Watched

■ Industry Watch

■ IBMI News

Information appearing on this website (images and texts, unless otherwise indicated) is the property of IBMI. To use or share, please indicate the source.

Address：9F., No. 508, Sec. 7, Zhongxiao E. Rd., Nangang Dist., Taipei City , Taiwan (R.O.C.) Contact Number：(02)2655-8168 Fax：(02)2655-7978